Piclin

Quick links to important sections

Piclin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Piclin

Property Description
Active ingredient Sodium Picosulfate (INN)
Form Tablet, Syrup, Oral Solution
Pharmacological class Stimulant Laxative (Gastrointestinal Agent)
Origin Synthetic (Diphenylmethane Derivative)
General purpose Relief of constipation and bowel cleansing

Piclin is a medicine featuring the active ingredient Sodium Picosulfate (INN), and it is formally classified as a stimulant laxative. This classification places it within the broader group of Gastrointestinal Agents used to promote bowel movements. Its primary purpose is to address situations requiring efficient, predictable relief, such as occasional constipation or complete bowel preparation before diagnostic procedures. Sodium Picosulfate is a reliable agent for achieving effective colon clearing, particularly when used in protocols for procedural preparation.

The drug is a synthetic compound, chemically a Diphenylmethane Derivative, designed exclusively for the oral route of administration. Piclin is available in the liquid forms of Syrup and Oral Solution, in addition to the Tablet form, offering flexibility for patient preference. It functions as an inactive prodrug until it reaches the large intestine, where it is metabolized by colonic bacteria into its active form. This local activation mechanism is key to its efficacy, as the active metabolite directly stimulates the colon wall to increase muscle contractions, ensuring efficient evacuation. This targeted, contact-based mechanism differentiates it from bulk-forming or osmotic laxatives, confirming its clinical utility for scenarios demanding reliable propulsive activity.

Regulatory References

  1. National Library of Medicine (NIH) on Sodium Picosulfate

What side effects are possible with Piclin?

Possible Side Effects and Safety Information

The following information outlines the official adverse reactions and safety characteristics of medicines containing Sodium Picosulfate, strictly based on regulatory documents from governmental health authorities.

Official Classification of Common Adverse Reactions

Adverse reactions associated with Sodium Picosulfate are grouped by the System Organ Class (SOC) they affect, and by frequency based on clinical trial and post-marketing data presented in regulatory documents. Reactions affecting the Gastrointestinal System are commonly observed.

Frequency Classification Examples of Adverse Reactions (Official Documentation)
Very Common (ge 1/10) Diarrhoea
Common (ge 1/100 to < 1/10) Headache, Abdominal pain/cramps, Nausea, Vomiting

Documented Serious Safety Characteristics

Regulatory sources mandate specific warnings regarding the potential for Serious Fluid and Electrolyte Abnormalities (such as Hyponatraemia or Hypokalaemia) due to significant fluid evacuation. The consequences of severe imbalance are documented to include the risk of Seizures, Cardiac Arrhythmias, and Renal Impairment. Rare but serious gastrointestinal concerns explicitly noted in official labeling include the potential for Colonic Mucosal Ulceration and Ischemic Colitis.

Population-Specific and Contextual Safety Notes

  • Severe Renal Impairment: The medication is formally contraindicated in individuals with severely reduced renal function (creatinine clearance less than 30 mL/minute).
  • Exposure-Related Safety: Prolonged or excessive use of this class of stimulant laxatives may be associated with fluid and electrolyte disturbances and the development of cathartic colon.
  • Restrictions: The product is contraindicated in patients with conditions such as Gastrointestinal obstruction or perforation, Ileus, and Severe dehydration.

This classification reflects how government regulatory documents organize and communicate the medicine’s safety profile.

Overdose and Emergency Response

Overdose Risk and Emergency Action for Piclin

Overdose or improper use of bulk-forming laxatives, such as those containing psyllium (the active ingredient in Piclin), is officially documented as primarily carrying the risk of esophageal obstruction or intestinal blockage. This severe physical consequence occurs when the fiber swells rapidly without sufficient fluid, potentially blocking the throat or esophagus.

Regulatory documents emphasize that taking a large amount in a single dose, especially without the recommended amount of liquid, is the main exposure factor associated with this risk.

Immediate Medical Attention Required

Urgent medical help must be sought immediately if the following symptoms occur after taking this product:

  • Chest pain
  • Vomiting
  • Difficulty in swallowing
  • Difficulty in breathing

These symptoms can indicate a serious physical obstruction or a severe allergic reaction and require immediate emergency care. The risk of obstruction is considered an unacceptable safety risk by regulators for certain dosage forms if warnings are not followed.

Individuals who have a history of difficulty in swallowing should be cautioned against using the product. If an overdose is suspected, contacting a local poison control center or emergency services is the required first step for professional guidance.

Therapeutic Uses of Piclin

Main Uses and Indications

Piclin is primarily utilized for the management of constipation. It is indicated for patients who experience difficulty with regular bowel movements or infrequent evacuation. The medication is also employed in clinical settings to clear the colon in preparation for diagnostic procedures, such as endoscopy, radiological examinations, or surgical interventions that require the bowel to be empty.

Mechanism of Action

The active ingredient in Piclin is sodium picosulfate, a stimulant laxative. It remains inactive as it passes through the stomach and small intestine. Upon reaching the colon, it is metabolized by naturally occurring bacteria into its active form. This active metabolite works by directly stimulating the nerve endings in the intestinal wall, which increases peristalsis—the wave-like muscle contractions that move contents through the digestive tract.

Additionally, the medication promotes the accumulation of water and electrolytes within the intestinal lumen. This process softens the stool and increases its volume, further facilitating easier passage and evacuation.

Expected Benefits

Relief of Constipation

By enhancing intestinal motility and softening stool consistency, Piclin helps restore more regular bowel movements. It is effective in addressing various forms of constipation, including chronic cases or those associated with specific medical conditions, provided the underlying cause has been evaluated.

Bowel Cleansing

In a clinical context, the primary benefit of Piclin is its ability to thoroughly evacuate the bowel. This ensures a clear field of view for medical professionals during internal examinations, which is essential for the accuracy of diagnostic imaging and the safety of surgical procedures.

Predictable Activity

Because the medication requires bacterial activation in the large intestine, there is a characteristic delay between administration and the onset of effect. This allows for a level of predictability regarding when bowel movements will occur, typically several hours after intake.

Eligibility and Restrictions for Use

Piclin (Sodium Picosulfate) is a stimulant laxative used to treat occasional constipation. However, it is not suitable for everyone and certain medical conditions or circumstances restrict its use.

Contraindications (Who Should Not Use Piclin)

Piclin is typically contraindicated if you have any of the following conditions:

  • Allergy to sodium picosulfate or any other ingredient in the product.
  • Severe dehydration.
  • Intestinal obstruction (ileus), gastrointestinal perforation, or ulceration.
  • Acute inflammatory bowel diseases or acute abdominal surgical conditions like appendicitis.
  • Severe, undiagnosed abdominal pain accompanied by nausea and vomiting.

Use with Caution and Special Populations

Certain groups should use Piclin only under strict medical supervision due to increased risks:

  • Children: Use is generally not recommended for children under 10 or 12 years of age, depending on the formulation and authority guidelines.
  • Pregnancy and Breastfeeding: Consult a healthcare provider. While some sources suggest caution, other data indicates potential risks, particularly in pregnancy, and use should be avoided unless clearly necessary.
  • Liver Disease: Individuals with liver problems may require caution.
  • Elderly Patients: Use with caution, as older adults may be more susceptible to dehydration and electrolyte imbalance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the product's interaction structure primarily around two clinical effects: reduced absorption of co-administered oral drugs and an additive risk of fluid and electrolyte disturbance.

Interaction Scope

Classification Interacting Agents / Conditions Official Regulatory Statement
Reduced Absorption (PK Effect) All Oral Medications The accelerated gastrointestinal transit caused by the product may reduce the systemic absorption of other oral medicines taken concurrently.
Chelation / Absorption Tetracycline and Fluoroquinolone Antibiotics, Iron Supplements, Digoxin, Chlorpromazine, Penicillamine The magnesium component in combination products can chelate and prevent the absorption of these specific agents.
Pharmacodynamic (PD Effect) Diuretics, Corticosteroids, ACE Inhibitors, NSAIDs Co-administration with these agents may increase the officially documented risk of fluid and electrolyte abnormalities, such as hypokalemia.
Pharmacodynamic Cardiac Glycosides (e.g., Digoxin) Due to the risk of electrolyte disturbance, patients taking these agents are at increased sensitivity to cardiotoxicity.
Pharmacodynamic Other Laxatives Concomitant use with other laxative products is advised against due to the risk of an additive effect on bowel activity.

Timing-Based Regulatory Rules:

The reduced absorption domain necessitates specific mandatory timing separation rules. Administration of all oral medications must be avoided within one hour of starting the product. Furthermore, specific agents, including the listed antibiotics and iron supplements, must be taken at least 2 hours before and not less than 6 hours after administration.

Population-Specific and Contextual Constraints:

Use with caution is required in patients with renal impairment due to the increased risk of magnesium accumulation when combined with medications that affect renal function. Additionally, official regulatory instructions advise against the consumption of alcohol, solid food, or dairy during use for bowel cleansing due to their potential to compromise the product's intended action.

Mechanism of Action

Activation by Colonic Bacteria

Piclin's active ingredient is an inactive prodrug that requires an essential first step: conversion into the active metabolite, BHPM, by bacterial enzymes (desulfatase) found only in the large intestine. The mechanism limits systemic exposure and is localized to the colon.


Stimulating Colonic Motility

Once active, BHPM acts as a contact stimulant, directly triggering the sensory nerve endings within the colonic wall. This nerve activation initiates a significant increase in the frequency and force of muscular contractions (peristalsis), which is the force accelerating the movement of contents through the large intestine.


Modulating Water and Electrolyte Transport

Simultaneously, the active metabolite modifies epithelial function by inhibiting the reabsorption of water and electrolytes from the colonic lumen while promoting fluid secretion. This physiological change significantly increases the water content and volume of the stool mass, softening the contents and combining with the enhanced motility to facilitate colonic evacuation.

Dosage and Administration Information

How to Use Piclin: Official Administration Guidelines

Piclin, which contains the active ingredient Sodium Picosulfate, is approved exclusively for oral administration. The dosage, frequency, and duration of use are strictly determined by the usage context, either for short-term constipation relief or for procedural bowel cleansing.


Dosing for Short-Term Constipation Relief

The standard adult dosing regimen is typically 5 mg to 10 mg of sodium picosulfate, administered once daily. It is recommended to take the dose at bedtime to produce an effect the following morning. The maximum recommended dose should not be exceeded. Use for constipation should not be on a continuous daily basis for more than five days.


Procedural Bowel Cleansing Regimen

For colon cleansing prior to a procedure, a fixed two-dose regimen is required, with each dose containing 10 mg of sodium picosulfate. The preferred schedule is the Split-Dose Regimen: the first dose is taken the evening before the procedure, and the second dose is taken approximately 5 hours before the procedure on the following morning.

This procedural use mandates specific preparation: powder forms must be dissolved in cold water immediately before intake, whereas ready-to-drink solutions are consumed directly. Crucially, the regimen requires mandatory consumption of additional clear liquids after each dose, and the entire treatment period must not exceed 24 hours.


Administration Requirements

  • Route: Oral administration only.
  • Duration Limit (Constipation): Not to be used continuously for more than five days.
  • Fluid Intake: Adequate fluid intake is essential during treatment, particularly with the bowel cleansing regimen.
  • Age Rules: For bowel cleansing, the adult regimen is used for pediatric patients aged 9 years and older.

These guidelines define the standardized parameters for administration, including dose titration for constipation and the strict two-dose, time-bound protocol for procedural preparation, ensuring use aligns with official documentation.

Recent Clinical Evidence

Piclin: Recent Clinical Evidence

Clinical research on formulations containing Piclin (Sodium Picosulfate) primarily focuses on evaluating its short-term use for occasional constipation relief and for bowel clearance before medical procedures like colonoscopy or surgery.

Efficacy in Chronic Constipation

A double-blind, randomized, placebo-controlled study investigated the acute use of sodium picosulfate in patients with chronic constipation. The research found that a significantly higher percentage of participants receiving sodium picosulfate reported a treatment response (defined as improvement in stool frequency and straining) compared to the placebo group over the treatment period. Furthermore, the active treatment was associated with a greater reduction in reported bloating.

Safety and Tolerability Profile

Across multiple studies, sodium picosulfate has generally been documented as well-tolerated during short-term use. Adverse events reported were typically gastrointestinal in nature and included abdominal discomfort, diarrhea, and cramps. These side effects were generally mild.

One key finding from these trials is the monitoring of electrolytes and cardiovascular effects. Monitoring data from the acute use study indicated no significant changes in serum electrolytes (like potassium) or cardiovascular parameters between the sodium picosulfate group and the placebo group over the study duration.

Use in Combination Formulations

Some research has explored formulations where sodium picosulfate is combined with other laxatives, such as liquid paraffin and milk of magnesia. These combination studies found that the combined agents were associated with improvements in measures like stool frequency, consistency, and straining across patients with chronic constipation complicated by conditions like anal fissures or hemorrhoids. The tolerability of the combination therapy was also generally noted as good in the context of the study period.

Key Studies & References

  1. A pilot study on the efficacy of Picolax given as a four-week course for the treatment of refractory constipation
  2. Public Assessment Report of over-the-counter stimulant laxatives: benefit-risk review (MHRA/UK Regulatory)

Frequently Asked Questions (FAQ)

Common questions about Piclin (FAQ)


Q: How quickly should Piclin start working after I take it?

A: Official regulatory documents indicate that the therapeutic effect of Piclin generally begins between 6 to 12 hours after you take the oral dose. This timing aligns with the usual recommendation to take the dose at bedtime for a morning effect.


Q: Does Piclin soften the stool, increase bowel movement, or both?

A: Piclin's mechanism of action involves both effects. Its active form works by stimulating the muscular contractions in the colon (peristalsis) to increase bowel movement, and it also increases the water content of the stool, which helps to soften it.


Q: Is it normal to have some abdominal cramping after taking Piclin?

A: Yes, regulatory documents list abdominal cramps or pain as a Common side effect associated with the use of Piclin. These effects are typically mild and occur because the medication stimulates muscle contractions in the colon.


Q: Can Piclin cause an imbalance in electrolytes, and what does that mean?

A: Official warnings state that the medication may lead to serious fluid and electrolyte abnormalities—such as low potassium (hypokalemia)—due to the significant fluid loss it causes. Severe imbalance could potentially lead to complications like cardiac arrhythmias or seizures. Adequate hydration is emphasized in product warnings to help prevent these imbalances.


Q: Does Piclin interact with any common over-the-counter pain relievers?

A: Regulatory documents indicate that taking Piclin with non-steroidal anti-inflammatory drugs (NSAIDs), which include some over-the-counter pain relievers, may increase the risk of fluid and electrolyte abnormalities. Individuals should consult the official product information or a healthcare professional to check for potential interactions with specific over-the-counter pain relievers.


Q: Should I wait a certain amount of time between taking Piclin and other oral medications?

A: Yes. To reduce the risk of Piclin affecting the body’s absorption of other medicines, official rules state that the administration of all oral medications must be avoided within one hour of starting Piclin.


Q: Is Piclin known to interfere with the absorption of birth control pills?

A: Because Piclin speeds up the movement of contents through the gut, there is a risk it may interfere with the body's absorption of other medications, including oral contraceptives (birth control pills). Regulatory information for related products advises that this effect is possible.


Q: Why is Piclin often recommended to be taken at bedtime?

A: Piclin is recommended to be taken at bedtime because its effect typically takes 6 to 12 hours to begin working. Taking it in the evening aims for a predictable bowel movement the following morning.


Q: What is the typical timeframe for a bowel movement to occur after taking Piclin?

A: The therapeutic effect usually begins within 6 to 12 hours after you take a dose. This predictable timeframe is a key characteristic of this type of stimulant laxative.


Q: Is it possible for Piclin to cause nausea or vomiting?

A: Yes, official product information lists both nausea and vomiting as Common side effects that may occur with the use of Piclin. These effects are related to the medication’s action on the gastrointestinal system and are often transient.


Q: Why is it advised to drink plenty of fluids while using Piclin?

A: It is advised that adequate fluid intake is emphasized in regulatory warnings because the medication causes significant fluid loss during bowel evacuation. This is especially important during the bowel cleansing regimen, to help prevent dehydration and electrolyte imbalance.


Q: Are there any known withdrawal effects if I stop taking Piclin suddenly?

A: Regulatory documents warn that the prolonged or excessive use of stimulant laxatives may be associated with the development of dependency or 'cathartic colon.' However, Piclin is indicated for short-term use only, which is intended to mitigate the risk of developing dependency.


Q: What is Piclin used for, besides general constipation?

A: In addition to the short-term relief of occasional constipation, Piclin is officially used for bowel cleansing (also known as colon preparation). This is required before diagnostic procedures like a colonoscopy or certain types of surgery.


Q: Is Piclin considered a stimulant laxative or a bulk-forming laxative?

A: Piclin, which contains the active ingredient Sodium Picosulfate, is officially classified as a stimulant laxative (a Gastrointestinal Agent). This means it directly stimulates the nerves in the colon to cause a bowel movement, rather than adding bulk to the stool.


Q: Can Piclin be used for bowel preparation before a colonoscopy or surgery?

A: Yes, one of the official indications for Piclin is bowel cleansing before procedures, including colonoscopy or other medical procedures requiring a clean colon. The procedural use involves a specific, time-bound regimen.


Q: Does Piclin help with chronic constipation, or is it only for occasional use?

A: The officially approved use for Piclin is for the short-term relief of functional constipation. Continuous daily use is not recommended for more than five days. The appropriate use of this product for chronic constipation requires the guidance of a healthcare professional.


Q: Does Piclin come in a sugar-free formulation for people with diabetes?

A: While the active ingredient is consistent, some commercially available liquid formulations containing Sodium Picosulfate are produced as 'Sugar-Free' options. Such formulations are available for individuals managing their sugar intake.


Q: Can Piclin be used by elderly patients for occasional constipation?

A: Official guidance indicates that use in elderly patients requires caution. Older adults may be more susceptible to dehydration and electrolyte imbalance, and therefore, use in this population may require medical monitoring.


Q: Is it normal to feel a bit dizzy or lightheaded after using Piclin?

A: Dizziness has been noted as an adverse effect. Regulatory warnings note that the risk of dizziness or fainting may be increased by dehydration, especially during the rapid fluid loss associated with its use.


Q: Can taking Piclin affect the results of certain blood tests?

A: Yes. Piclin can cause disturbances in the body's mineral levels, such as low potassium (hypokalemia). These electrolyte disturbances can, in turn, alter the results of blood tests that measure these specific parameters.


Q: How long does the effect of one dose of Piclin typically last in the body?

A: Regulatory data indicates that the terminal half-life of the prodrug is approximately 7.4 hours, though the actual duration of the laxative effect can vary between individuals.


Q: Do children use a different formulation or dosage of Piclin compared to adults?

A: For the constipation indication, product information notes Piclin is generally not recommended for children below 10 years of age. For the bowel cleansing regimen, the adult dosing protocol is generally used for pediatric patients aged 9 years and older, as per regulatory guidelines.


Q: Can Piclin be taken on an empty stomach, or should it be taken with food?

A: The oral dose is typically taken at bedtime. When Piclin is used for the bowel cleansing regimen, official rules advise against consuming solid food or dairy during that period as they may interfere with the intended action.


Q: What should I do if I unintentionally take slightly more Piclin than intended?

A: Regulatory information warns that overdosage of laxatives may lead to serious complications, including severe electrolyte disturbances and dehydration. If an overdose is suspected, individuals should seek emergency medical attention immediately.


Q: Does Piclin interact negatively with high-fiber supplements like psyllium?

A: Regulatory information for related products advises that if an individual is currently taking a bulk-forming laxative (such as a fiber supplement), it is advised to discuss this with a healthcare professional.


Q: How should Piclin syrup or solution be measured for the correct dose?

A: Official instructions for the liquid forms of this medicine advise that the dose should be measured accurately using a measuring cup or dosing syringe. It is necessary to shake the bottle well before each use to ensure the medication is properly mixed.


Q: Can Piclin be safely used by a woman who is breastfeeding?

A: It is not known if the medication is excreted into human milk. Regulatory documents advise that caution should be exercised, and individuals who are breastfeeding are advised to consult a healthcare provider before using this product.


Q: What is the connection between Piclin and increased magnesium levels in the blood?

A: When sodium picosulfate is formulated with a magnesium-containing component, there is a risk of magnesium accumulation. Regulatory warnings advise particular caution in patients with renal impairment (kidney problems) due to this risk.


Q: Is Piclin considered habit-forming if used correctly for short periods?

A: Piclin is officially indicated only for short-term use. While prolonged or excessive use of stimulant laxatives can lead to laxative dependency or 'cathartic colon,' using the product for a short duration, as indicated, is intended to mitigate this risk.


Q: Does Piclin contain sodium, and is that a concern for people with high blood pressure?

A: The active ingredient is Sodium Picosulfate, meaning it contains sodium. While regulatory documents focus warnings on fluid and electrolyte imbalances, individuals concerned about sodium intake, such as those with high blood pressure, typically consult a healthcare provider.


Q: Is Piclin safe to use for a person with a history of liver disease?

A: Official product information states that the medication must be used with caution in patients with a history of liver disease. Individuals with liver problems may need to consult a healthcare professional for specific guidance on use.


Q: What signs indicate that a mild side effect from Piclin is becoming more serious?

A: Signs of a serious problem include symptoms of severe fluid and electrolyte abnormalities (such as severe dizziness, weakness, or changes in heart rhythm), severe abdominal pain, or symptoms related to rare but serious complications like colonic mucosal ulceration.


Q: Is there any risk of an allergic reaction to the ingredients in Piclin?

A: Yes. Regulatory documents list a specific contraindication (a condition that forbids use) for people with a known allergy or hypersensitivity to sodium picosulfate or any other inactive ingredient in the product.


Q: Why is it important to shake the oral solution form of Piclin before use?

A: Instructions for the oral solution form advise that it is important to shake the bottle well before each use. This is necessary to ensure that the medication is properly mixed throughout the liquid so you can consistently administer the correct dose.

How should Piclin be stored and disposed of?

How to Store and Dispose of Piclin?

Strict adherence to the official storage and disposal instructions is required to maintain product stability and ensure public safety.

Storage Requirements

The medicine must be kept out of the sight and reach of children.

Condition Requirement
Environmental Protection Store in the original package to protect from moisture, heat, and direct light (Store below 30 C for some formulations; Do not freeze or refrigerate specific solutions).
Stability Do not use after the expiry date. Sachets must be used immediately once opened, and any unused portion must be discarded.

️ Disposal Instructions

Properly dispose of unused or expired medicine to protect the environment. It is mandated not to dispose of the product via wastewater or regular household waste. Individuals should ask a pharmacist for guidance on utilizing local take-back programs or following specific regulations for throwing away medicines they no longer need.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Piclin found in:

A-Z Index: